期刊文献+

制定基于风险的临床检验质量控制计划 被引量:3

下载PDF
导出
摘要 随着检测系统技术的发展,质量控制的概念已经从主要监测检测系统稳定性转变为管理报告不正确患者结果的风险。为此美国临床和实验室标准化研究院(CLSI)成立了委员会以制订实验室内基于风险管理的质量控制计划指南,采用风险管理技术制订实验室个性化质量控制计划。基于风险的质量控制计划可成本有效地管理报告不正确结果的风险并满足监管要求。CLSI文件EP23-A为该过程提供了指南,指出制订质量控制计划步骤包括:收集检测过程的信息;评估过程风险;制订质量控制计划以消除风险;实施、监测和更新计划。现主要根据风险管理原理和CLSI EP23-A为制订质量控制计划提供一些参考。
出处 《检验医学与临床》 CAS 2016年第4期568-570,共3页 Laboratory Medicine and Clinic
  • 相关文献

参考文献11

  • 1康凤凤,王治国.临床实验室质量控制中的风险管理[J].临床检验杂志,2012,30(7):539-542. 被引量:17
  • 2康凤凤,王薇,王治国.基于风险管理的临床实验室质量控制[J].国际检验医学杂志,2012,33(21):2673-2674. 被引量:9
  • 3王治国编著..临床检验质量控制技术[M].北京:人民卫生出版社,2004:358.
  • 4CLSI/NCCLS C24. Statistical quality control for quantita-tive measurement procedures. Approved guideline [S]. Wayne (PA): National Center for Clinical Laboratories, 1991. 被引量:1
  • 5Parvin CA. Assessing the impact of the frequency of qual- ity control testing on the quality of reported patient re- suits[J]. Clin Chem, 2008,54(12) : 2049-2054. 被引量:1
  • 6CMS. State Operations Manual, Appendix C, Survey pro cedures and interpretive comments for laboratories and la boratory services [OL]. 2012-10-12. http://www, cms gov/Regulations-and Guidance/Legislation/CLIA/Inter pretive_Guidelines for Laboratories. html. 被引量:1
  • 7Clinical and Laboratory Standards Institute. EP23 A Labora- tory quality control based on risk management; approved guideline[S]. Wayne, PA, USA: CLSI, 2011. 被引量:1
  • 8康凤凤,王治国.失效模式和效应分析在减少检验医学差错中的应用[J].中国医院,2012,16(9):37-39. 被引量:10
  • 9ISO Document 14971. Medical devices-application of risk management to medical devices [S]. Geneva (Switzer- land) : International Standard Organization, 2007. 被引量:1
  • 10Nichols JH. Laboratory quality control based on risk management[J]. Ann Saudi Med,2011,31(3) :223-228. 被引量:1

二级参考文献31

  • 1ISO 31000. Risk management-principles and guidelines[ S]. Interna- tional Organization for Standardization ,2009. 被引量:1
  • 2ISO/IEC Guide 73. Risk management-vocabulary [ S ]. Intenaational Organization for Standardization ,2009. 被引量:1
  • 3CLSI EP23-A. Laboratory quality control based on risk management; approved guideline [ S ]. Clinical and Laboratory Standards Institute, 2011. 被引量:1
  • 4ISO 15198. Clinical laboratory medicine-in vitro diagnostic medical devices-validation of user quality control procedures by the manufac- turer[S]. International Organization for Standardization, 2004. 被引量:1
  • 5Bonini P, Plebani M, Ceriotti F, et al. Errors in laboratory medicine [J]. Clin Chem,2002, 48(5) :691-698. 被引量:1
  • 6ISO 14971. Medical devices-application of risk management to medi- cal devices[S]. International Organization for Standardization,2007. 被引量:1
  • 7ISO/TS 22367. Medical laboratories-reduction of error through risk management and continual improvement [ S ]. International Organiza- tion for Standardization,2008. 被引量:1
  • 8Joint Commission on Accreditation of Health Care Organizations. Performance improvement. 2002 Comprehensive accreditation manual for hospitals[S]. Oakbrook Terrace, 1L: Joint Commission on Accreditation of Health care Organizations, 2001 : 200-1. 被引量:1
  • 9ISO.Medical laboratories- reduc, tion of error through risk management and continual improvementlS]. ISO /TS 22367:2008, Geneva, Switzerland: International Organization h~r Standardization. 2008. 被引量:1
  • 10McDermott RE, Mikulak RJ, Beauregard MR. The basis of FMEA[M]. New York: Quality Resources,1996. 被引量:1

共引文献23

同被引文献15

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部